1 May 2020 - Deborah Wilkes
Premium
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 46% at constant exchange rates in the first quarter of 2020, following consolidation of Pfizer’s Consumer Healthcare products and the COVID-19 pandemic.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.